CRISMAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CRISMAB
Largest movements
- Financial fixed assets -€136,700
no longer reported in 2024 (was €136,700)
- Other debts -€136,047
down €136,047 (-15.5%), from €875,491 to €739,443
- Financial charges +€1.5m
up €1.5m (+31,700%), from €4,650 to €1.5m
of which Non-recurring financial charges: +€1.5m
- Gross operating margin +€1.5m
up €1.5m (+29,322%), from €5,024 to €1.5m
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €154,965 | €18,117 | -€136,849 | -88.3% |
| Fixed assets | 21/28 | €136,700 | - | -€136,700 | |
| Financial fixed assets | 28 | €136,700 | - | -€136,700 | |
| Current assets | 29/58 | €18,266 | €18,117 | -€149 | -0.8% |
| Amounts receivable within one year | 40/41 | €7,573 | €7,593 | +€20 | +0.3% |
| Other amounts receivable | 41 | €7,573 | €7,593 | +€20 | +0.3% |
| Cash at bank and in hand | 54/58 | €10,693 | €10,524 | -€169 | -1.6% |
| Total equity and liabilities | 10/49 | €154,965 | €18,117 | -€136,849 | -88.3% |
| Equity | 10/15 | -€720,607 | -€721,327 | -€720 | -0.1% |
| Contributions | 10/11 | €175,000 | €175,000 | = | 0.0% |
| Capital | 10 | €175,000 | €175,000 | = | 0.0% |
| Issued capital | 100 | €175,000 | €175,000 | = | 0.0% |
| Reserves | 13 | €17,500 | €17,500 | = | 0.0% |
| Non-distributable reserves | 130/1 | €17,500 | €17,500 | = | 0.0% |
| Legal reserve | 130 | €17,500 | €17,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€913,107 | -€913,827 | -€720 | -0.1% |
| Amounts payable | 17/49 | €875,572 | €739,443 | -€136,129 | -15.5% |
| Amounts payable within one year | 42/48 | €875,572 | €739,443 | -€136,129 | -15.5% |
| Trade debts | 44 | €82 | - | -€82 | |
| Suppliers | 440/4 | €82 | - | -€82 | |
| Other amounts payable | 47/48 | €875,491 | €739,443 | -€136,047 | -15.5% |
| Non-recurring operating income | 76A | €6,391 | €1,478,414 | +€1.5m | +23,031% |
| Goods, raw materials, services and sundry goods | 60/61 | €1,368 | €391 | -€977 | -71.4% |
| Non-recurring operating charges | 66A | - | €180 | +€180 | |
| Gross operating margin | 9900 | €5,024 | €1,478,024 | +€1.5m | +29,322% |
| Operating profit (loss) | 9901 | €5,024 | €1,477,844 | +€1.5m | +29,318% |
| Financial charges | 65/66B | €4,650 | €1,478,563 | +€1.5m | +31,700% |
| Recurring financial charges | 65 | €143 | €149 | +€6 | +4.2% |
| Non-recurring financial charges | 66B | €4,507 | €1,478,414 | +€1.5m | +32,706% |
| Profit (loss) for the period before taxes | 9903 | €374 | -€720 | -€1,094 | |
| Profit (loss) for the period | 9904 | €374 | -€720 | -€1,094 | |
| Profit (loss) for the period to be appropriated | 9905 | €374 | -€720 | -€1,094 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.